[ASAP] Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer š Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.3c01063 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
